To establish the proof of concept that Nutrabiotix fiber is safe and well tolerated, promotes gut health by increasing production of short chain fatty acids and changes colonic microbiota composition in favor of bifidobacteria, improves bowel habit and increase in stool weight. To this end, we will conduct a randomized, double blind, controlled, dose ranging, 3 arm trial in 120 healthy subjects comparing two doses of the Nutrabiotix fiber to psyllium fiber.

Public Health Relevance

The completion of this project will prove the efficacy and tolerability of Nutrabiotix fiber in humans and will form the basis of commercializing a well tolerated natural carbohydrate product with targeted delivery to the colon that promotes """"""""gut health"""""""" and potentially, prevents and treats colonic diseases where changes in the gut microbiota and/or colonic milieu play a key pathogenic role.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43DK088525-01
Application #
7916301
Study Section
Special Emphasis Panel (ZRG1-DKUS-F (10))
Program Officer
Densmore, Christine L
Project Start
2010-05-01
Project End
2012-04-30
Budget Start
2010-05-01
Budget End
2012-04-30
Support Year
1
Fiscal Year
2010
Total Cost
$247,561
Indirect Cost
Name
Nutrabiotix, LLC
Department
Type
DUNS #
826373792
City
West Lafayette
State
IN
Country
United States
Zip Code
47906